ZMUni Compliance Centre

  Pet Economy Boom in China    In recent years, China's "pet economy" has seen rapid growth, fueled by expanding consumer demand and investment.   According to the 2023-2024 China Pet Industry White Paper, the number of pet dogs reached 51.75 million in 2023, up 1.1% from 2022, while pet cats grew to 69.8 million, a 6.8% increase. This steady rise in pet ownership reflects the growing potential of China’s pet market, offering significant opportunities for future growth.   Year Dog (million) Cat (million) 2020 52.22 48.62 2021 54.29 58.06 2022 51.19 65.36 2023 51.75 69.80 Table 1: Changes in Dog

  On Aug. 26th, 2024, ZMUni Compliance Centre hosted a webinar titled “Towards Cruelty-Free Cosmetics: Exploring China's Compliance Requirements for New Cosmetic Ingredients of HoSU and Polymers” presented by our Senior Compliance Consultant Lolita Yang and Regulatory Analyst Kimberly Jin.        In the previous episodes, we covered the key highlights of the Animal Testing Alternatives in China and NCI with a focus on the History of Safe Use section from the webinar.   Today, we'll wrap up with the final section, highlighting NCI of polymers and important points to note for NCI applications, as presented in the webinar.     | Polymers

  On Aug. 26th, 2024, ZMUni Compliance Centre hosted a webinar titled “Towards Cruelty-Free Cosmetics: Exploring China's Compliance Requirements for New Cosmetic Ingredients of HoSU and Polymers” presented by our Senior Compliance Consultant Lolita Yang and Regulatory Analyst Kimberly Jin.       This webinar focused on the following five key parts:   1.Background: Get Ready for China’s NCI Regulatory Regime 2.China to Accept Animal-alternative Test Data under Specific Conditions 3.Understanding the Application under Situation 3 and 5, NCI with HoSU 4.Understanding the Application under Situation 6, NCI of Polymer 5.Points to Note for NCI Application in China   The

  On Aug. 26th, 2024, ZMUni Compliance Centre hosted a webinar titled “Towards Cruelty-Free Cosmetics: Exploring China's Compliance Requirements for New Cosmetic Ingredients of HoSU and Polymers” presented by our Senior Compliance Consultant Lolita Yang and Regulatory Analyst Kimberly Jin.   This webinar focused on the following five key parts:   1.Background: Get Ready for China’s NCI Regulatory Regime 2.China to Accept Animal-alternative Test Data under Specific Conditions 3.Understanding the Application under Situation 3 and 5, NCI with HoSU 4.Understanding the Application under Situation 6, NCI of Polymer 5.Points to Note for NCI Application in China   The following is

  | What happened?   Chinese beauty brand WINONA , a subsidiary of Botanee Group, is facing controversy over allegations that it improperly added preservatives to its products. The claims were made by a famous vlogger of product review Wang Hai, who posted a video on his social media platform, "Wang Hai Reviews," accusing WINONA of concealing its use of the preservative phenoxyethanol. The video reported that phenoxyethanol was detected in various batches of the same product purchased from multiple e-commerce platforms, with concentrations ranging from 0.137% to 0.140%.   In response to these allegations, WINONA issued a statement acknowledging the presence

Under China’s Food Safety Law, food is categorized into general and special food, the latter including health food, food for special medical purposes (FSMP), and infant formula food. FSMP is specially processed and formulated to meet the unique nutritional or dietary needs of individuals with dietary restrictions, digestive and absorption disorders, metabolic disorders, or specific diseases. FSMP in China is subject to registration management and must be used under the guidance of a physician or clinical nutritionist.   Current State of FSMP in China: While FSMP is a relatively new concept in China, its market is rapidly expanding. Despite initial challenges,

On Aug. 5th, 2024, ZMUni Compliance Centre hosted a webinar titled “New Cosmetic Ingredients in China: Emerging Trends & Latest Regulatory Updates” presented by our Consulting Expert Chris Wang.   This webinar focused on the following four key parts: China's New Cosmetic Ingredients: Emerging Trends and Insights since 2021 China's Evolving New Cosmetic Ingredients Regulations Compliance Considerations for Global Cosmetic Ingredient Companies Capitalizing on China's Dynamic Cosmetics Landscape: Good Timing? The following is a selection of highlights from the presentation slides：   | China’s Reformed Regulatory Framework for Cosmetic Ingredient | Overview of Notified NCI in China since 2021  | Notified

  China Cosmetic Regulatory Updates   | New Cosmetics Ingredients (NCI)   In July 2024, 9 new cosmetic ingredients were filed with the China National Medical Products Administration (NMPA). They include:   Ingredient Name in CN Filing No. Filer in CN 无柄灵芝菌丝体发酵产物滤液 20240047 水羊生物 亚异丙基甘油 20240048 索尔维（上海） 鸢尾苷元 20240049 上海澄穆 紫檀芪 20240050 柏瑞医药 苦参碱水杨酸盐 20240051 敷尔佳 10-羟基-2-癸烯酸 20240052  福瑞达 金线莲（ANOECTOCHILUS ROXBURGHII）提取物 20240053 远想生物 梁王茶（METAPANAX DELAVAYI）提取物 20240054 贝泰妮 乳酸杆菌/小粒咖啡（COFFEA ARABICA）籽发酵产物滤液 20240055 护家科技   The technical requirements for the 9 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the monitoring period.   Additionally, by the first half of 2024, 46